326 related articles for article (PubMed ID: 10648719)
21. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.
Van Pett K; Viau V; Bittencourt JC; Chan RK; Li HY; Arias C; Prins GS; Perrin M; Vale W; Sawchenko PE
J Comp Neurol; 2000 Dec; 428(2):191-212. PubMed ID: 11064361
[TBL] [Abstract][Full Text] [Related]
22. Corticotropin-releasing factor mediates the antinociceptive action of nitrous oxide in rats.
Sawamura S; Obara M; Takeda K; Maze M; Hanaoka K
Anesthesiology; 2003 Sep; 99(3):708-15. PubMed ID: 12960557
[TBL] [Abstract][Full Text] [Related]
23. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.
Li C; Vaughan J; Sawchenko PE; Vale WW
J Neurosci; 2002 Feb; 22(3):991-1001. PubMed ID: 11826127
[TBL] [Abstract][Full Text] [Related]
24. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
[TBL] [Abstract][Full Text] [Related]
25. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
26. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
Laflamme N; Bovetto S; Richard D; Rivest S
Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
[TBL] [Abstract][Full Text] [Related]
27. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
28. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
Henry BA; Lightman SL; Lowry CA
J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
[TBL] [Abstract][Full Text] [Related]
29. The effect of CRF2 receptor antagonists on rat conditioned fear responses and c-Fos and CRF expression in the brain limbic structures.
Skórzewska A; Lehner M; Hamed A; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Płaźnik A
Behav Brain Res; 2011 Aug; 221(1):155-65. PubMed ID: 21376756
[TBL] [Abstract][Full Text] [Related]
30. Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus.
Staub DR; Spiga F; Lowry CA
Brain Res; 2005 May; 1044(2):176-89. PubMed ID: 15885216
[TBL] [Abstract][Full Text] [Related]
31. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
J Neuroendocrinol; 2001 Apr; 13(4):328-38. PubMed ID: 11264720
[TBL] [Abstract][Full Text] [Related]
32. Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
Maillot C; Million M; Wei JY; Gauthier A; Taché Y
Gastroenterology; 2000 Dec; 119(6):1569-79. PubMed ID: 11113078
[TBL] [Abstract][Full Text] [Related]
33. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
34. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats.
Chen CY; Inui A; Asakawa A; Fujino K; Kato I; Chen CC; Ueno N; Fujimiya M
Gastroenterology; 2005 Jul; 129(1):8-25. PubMed ID: 16012930
[TBL] [Abstract][Full Text] [Related]
35. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.
Yuan PQ; Million M; Wu SV; Rivier J; Taché Y
Neurogastroenterol Motil; 2007 Nov; 19(11):923-36. PubMed ID: 17973638
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing factor and systemic capsaicin-sensitive afferents are involved in abdominal surgery-induced Fos expression in the paraventricular nucleus of the hypothalamus.
Bonaz B; Taché Y
Brain Res; 1997 Feb; 748(1-2):12-20. PubMed ID: 9067440
[TBL] [Abstract][Full Text] [Related]
37. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
Spiga F; Lightman SL; Shekhar A; Lowry CA
Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
[TBL] [Abstract][Full Text] [Related]
38. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
39. Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal Fos expression.
Rassnick S; Hoffman GE; Rabin BS; Sved AF
Neuroscience; 1998 Jul; 85(1):259-68. PubMed ID: 9607717
[TBL] [Abstract][Full Text] [Related]
40. Activation of corticotropin-releasing factor receptor 2 in lateral septum negatively regulates maternal defense.
D'Anna KL; Gammie SC
Behav Neurosci; 2009 Apr; 123(2):356-68. PubMed ID: 19331459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
